Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIBAJUSTE: Ribavirin Dose Adaptation in Hepatitis C
NCT00485342Phase 3Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- Apr 2006
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of ribavirin in hepatitis C (HCV), sponsored by Hospices Civils de Lyon. Status: unknown.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00485342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485342.